Document Detail

In vitro localization of human neural stem cell neurogenesis by engineered FGF-2 gradients.
MedLine Citation:
PMID:  23147909     Owner:  NLM     Status:  MEDLINE    
The development of effective stem cell-based therapies for treating brain disorders is keenly dependent upon an understanding of how to generate specific neural cell types and organize them into functional, higher-order tissues analogous to those of the cerebral cortex. Studies of cortical development have revealed that the proper formation of the human cerebral cortex results from specific intercellular interactions and soluble signaling between the highly-proliferative region occupied by dividing neural stem cells and an adjacent region of active neurogenesis and neural migration. However, the factors responsible for establishing this key asymmetrical proliferative-neurogenic architecture are not entirely known. Fibroblast growth factor 2 (FGF-2) is observed in a ventricular-pial gradient during in vivo development and has been previously shown to have effects on both human neural stem cell (hNSC) proliferation and neurogenesis. Here we have adapted a microfluidic approach for creating stable concentration gradients in 3D hydrogels to explore whether FGF-2 gradients can establish defined regions of proliferation and neurogenesis in hNSC cultures. Exponential but not linear FGF-2 gradients between 0-2 ng mL(-1) were able to preferentially boost the percentage of TuJ1(+) neurons in the low concentration regions of the gradient and at levels significantly higher than in non-gradient controls. However, no gradient-dependent localization was observed for dividing hNSCs or hNSC-derived intermediate progenitors. These data suggest that exponential FGF2 gradients are useful for generating asymmetric neuron cultures, but require contributions from other factors to recapitulate the highly-proliferative ventricular zone niche. The relevance of the findings of this study to in vivo cortical development must be more cautiously stated given the artifactual nature of hNSCs and the inability of any in vitro system to fully recapitulate the chemical complexity of the developing cortex. However, it is quite possible that exponential FGF2 gradients are employed in vivo to establish or maintain an asymmetric distribution of neurons in the ventricular-pial axis of the developing cerebral cortex.
T M Keenan; J R Grinager; A A Procak; C N Svendsen
Related Documents :
24381309 - Tdp-43 causes differential pathology in neuronal versus glial cells in the mouse brain.
23052549 - Projections from the paralemniscal nucleus to the spinal cord in the mouse.
6209269 - Visual abstracting as a decision-making tool in the selection of mediated material.
22700769 - Refeeding-activated glutamatergic neurons in the hypothalamic paraventricular nucleus (...
23362279 - Cyr61, a matricellular protein, is needed for dendritic arborization of hippocampal neu...
24648009 - Involvement of irs-1 interaction with adam10 in the regulation of neurite extension.
21426929 - Assessment of temporal state-dependent interactions between auditory fmri responses to ...
21968979 - Prolonged elevation of serum neuron-specific enolase in children after clinical diagnos...
16197519 - Somato-motor inhibitory processing in humans: a study with meg and erp.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Integrative biology : quantitative biosciences from nano to macro     Volume:  4     ISSN:  1757-9708     ISO Abbreviation:  Integr Biol (Camb)     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-20     Completed Date:  2013-04-26     Revised Date:  2013-06-12    
Medline Journal Info:
Nlm Unique ID:  101478378     Medline TA:  Integr Biol (Camb)     Country:  England    
Other Details:
Languages:  eng     Pagination:  1522-31     Citation Subset:  IM    
Stem Cell and Regenerative Medicine Center, University of Wisconsin, 1111 Highland Ave., Madison, WI 53705, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Proliferation / drug effects
Cells, Cultured
Cerebral Cortex / cytology,  growth & development
Fibroblast Growth Factor 2 / administration & dosage*,  physiology
Microfluidic Analytical Techniques
Neural Stem Cells / cytology*,  drug effects*,  physiology
Neurogenesis / drug effects*,  physiology
Recombinant Proteins / administration & dosage
Systems Biology
Tissue Engineering
Reg. No./Substance:
0/Hydrogels; 0/Recombinant Proteins; 103107-01-3/Fibroblast Growth Factor 2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A mechanochemically synthesised solid solution enables engineering of the sorption properties of a W...
Next Document:  Travel and transplantation: travel-related diseases in transplant recipients.